Sucrase–Isomaltase Deficiency in Children with Functional Gastrointestinal Disorders
Journal of Clinical Medicine · 09.05.2026 · 15 (10) · 3639
DOI: 10.3390/jcm15103639 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 09.05.2026. Verfasst von Firdevs Kavas Demirci und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Pamukkale University Faculty of Medicine, 20160 Denizli, Türkiye. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Background
Congenital sucrase–isomaltase deficiency (CSID) may mimic functional gastrointestinal disorders (FGIDs) and is likely underrecognized in pediatric practice. This study aimed to determine the frequency of sucrase–isomaltase (SI) gene variants among children with FGIDs and to evaluate genotype–phenotype associations and treatment-related quality-of-life outcomes.
Methods
In this prospective cross-sectional study, children aged 0–18 years diagnosed with FGIDs according to Rome IV criteria were enrolled between May 2022 and January 2023. All patients underwent next-generation sequencing for SI gene variants. Clinical characteristics, FGID subtypes, and anthropometric data were recorded. Variant-positive patients received dietary sucrose restriction, and selected patients were treated with sacrosidase enzyme replacement. Symptom severity was assessed using the Numeric Rating Scale, and quality of life was evaluated with the Pediatric Quality of Life Inventory (PedsQL 4.0).
Results
Among 290 children with FGIDs, SI gene variants were identified in 17 patients (5.9%). Variants were more frequently detected in children with irritable bowel syndrome–like symptoms. Clinical presentation was heterogeneous, and no consistent genotype–phenotype correlation was observed. Dietary intervention was associated with symptom improvement in compliant patients, while sacrosidase therapy led to significant improvements in both child- and parent-reported PedsQL scores.
Conclusions
Sucrase–isomaltase deficiency is not uncommon among children with FGIDs and should be considered, particularly in those with IBS-like symptoms or diet-related complaints. Integrating genetic evaluation with targeted dietary and enzyme-based therapy may improve symptom control and quality of life in selected pediatric patients.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatrics, Pamukkale University Faculty of Medicine, 20160 Denizli, Türkiye.
- Division of Pediatric Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, Pamukkale University Faculty of Medicine, 20160 Denizli, Türkiye.
- Division of Pediatric Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, Suleyman Demirel University Faculty of Medicine, 32260 Isparta, Türkiye.
ORCID-Profile: Firdevs Kavas Demirci, Tuğba Gürsoy Koca, Abdulkerim Elmas
Zitieren
APA
Demirci, F. K., Koca, T. G., Elmas, A., & Akçam, M. (2026). Sucrase–Isomaltase Deficiency in Children with Functional Gastrointestinal Disorders. Journal of Clinical Medicine, 15(10), 3639. https://doi.org/10.3390/jcm15103639
Vancouver
Demirci FK, Koca TG, Elmas A, Akçam M. Sucrase–Isomaltase Deficiency in Children with Functional Gastrointestinal Disorders. Journal of Clinical Medicine. 2026;15(10):3639. doi:10.3390/jcm15103639
BibTeX
@article{Demirci2026,
author = {Demirci, Firdevs Kavas and Koca, Tuğba Gürsoy and Elmas, Abdulkerim and Akçam, Mustafa},
title = {Sucrase–Isomaltase Deficiency in Children with Functional Gastrointestinal Disorders},
journal = {Journal of Clinical Medicine},
year = {2026},
volume = {15},
number = {10},
pages = {3639},
doi = {10.3390/jcm15103639}
}
EUVIMED